Scarica l'app Stockscreener
6.56
1.55%
0.10
Dopo l'orario di chiusura:
6.57
0.01
+0.15%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CVRX Giù?
Forum
Previsione
Precedente Chiudi:
$6.46
Aprire:
$6.55
Volume 24 ore:
173.57K
Relative Volume:
0.46
Capitalizzazione di mercato:
$172.99M
Reddito:
$47.26M
Utile/perdita netta:
$-58.48M
Rapporto P/E:
-2.4252
EPS:
-2.7049
Flusso di cassa netto:
$-40.45M
1 W Prestazione:
-1.13%
1M Prestazione:
-11.71%
6M Prestazione:
-51.34%
1 anno Prestazione:
-30.36%
Intervallo 1D:
$6.55
$6.87
Intervallo di 1 settimana:
$6.20
$6.95
Portata 52W:
$4.2993
$18.55
Cvrx Inc Stock (CVRX) Company Profile
Nome
Cvrx Inc
Settore
Industria
Telefono
(763) 416-2850
Indirizzo
9201 WEST BROADWAY AVENUE, MINNEAPOLIS
Confronta CVRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CVRX
Cvrx Inc
|
6.56 | 172.99M | 47.26M | -58.48M | -40.45M | -2.7049 |
|
ABT
Abbott Laboratories
|
133.58 | 232.41B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.09 | 155.73B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
383.89 | 146.23B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
87.44 | 106.37B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.52 | 45.88B | 5.54B | 4.18B | 623.10M | 7.00 |
Cvrx Inc Stock (CVRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-09 | Downgrade | JP Morgan | Neutral → Underweight |
| 2025-01-14 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2024-09-10 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-07-11 | Reiterato | Lake Street | Buy |
| 2024-05-01 | Ripresa | Craig Hallum | Buy |
| 2024-05-01 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-05-01 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-01-31 | Iniziato | Lake Street | Buy |
| 2022-07-18 | Iniziato | Craig Hallum | Buy |
| 2021-07-26 | Iniziato | Canaccord Genuity | Buy |
| 2021-07-26 | Iniziato | Piper Sandler | Overweight |
| 2021-07-26 | Iniziato | William Blair | Outperform |
Mostra tutto
Cvrx Inc Borsa (CVRX) Ultime notizie
Top NASDAQ Stocks Kalkine CVRx, Inc. Amid Short Interest Shift - Kalkine Media
Jane Street Group LLC Sells 2,456 Shares of CVRx, Inc. (NASDAQ:CVRX) - Defense World
CVRx, Inc. (NASDAQ:CVRX) Shares Purchased by Bank of America Corp DE - Defense World
Short Interest in CVRx, Inc. (NASDAQ:CVRX) Increases By 19.4% - Defense World
CVRx, Inc. (NASDAQ:CVRX) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
CVRx Confirms Directors and Accounting Firm at Meeting - TipRanks
CVRx at William Blair Conference: Strategic Focus on Barostim - Investing.com
CVRx at William Blair Conference: Strategic Focus on Barostim By Investing.com - Investing.com UK
Nuveen Asset Management LLC Has $2.01 Million Position in CVRx, Inc. (NASDAQ:CVRX) - Defense World
Learn to Evaluate (CVRX) using the Charts - news.stocktradersdaily.com
Millennium Management LLC Sells 30,168 Shares of CVRx, Inc. (NASDAQ:CVRX) - Defense World
CVRx to Present at the William Blair 45th Annual Growth Stock Conference - GlobeNewswire
Medical Device Leader CVRx Showcases Cardiovascular Breakthroughs at Major Growth Conference - Stock Titan
CVRx, Inc. (NASDAQ:CVRX) Shares Acquired by Northern Trust Corp - Defense World
D. E. Shaw & Co. Inc. Cuts Stock Position in CVRx, Inc. (NASDAQ:CVRX) - Defense World
47,120 Shares in CVRx, Inc. (NASDAQ:CVRX) Purchased by BNP Paribas Financial Markets - Defense World
Long Term Trading Analysis for (CVRX) - news.stocktradersdaily.com
Monday 5/19 Insider Buying Report: HUM, CVRX - Nasdaq
Director Makes Bold Move with Massive CVRx Stock Purchase - TipRanks
CVRx Poised for Growth: Buy Rating Affirmed Amid Sales Restructuring and Potential Reimbursement Catalyst - TipRanks
Insider Buying: Kevin Hykes Acquires Additional Shares of CVRx I - GuruFocus
CVRx CEO Makes Bold Investment Move! - TipRanks
Wells Fargo & Company MN Has $113,000 Holdings in CVRx, Inc. (NASDAQ:CVRX) - Defense World
Barclays PLC Boosts Stake in CVRx, Inc. (NASDAQ:CVRX) - Defense World
(CVRX) Trading Advice - news.stocktradersdaily.com
Piper Sandler Has Lowered Expectations for CVRx (NASDAQ:CVRX) Stock Price - Defense World
CVRx, Inc. (NASDAQ:CVRX) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
CVRx Reports First Quarter 2025 Financial and Operating Results - ADVFN
CVRx, Inc. (NASDAQ:CVRX) Q1 2025 Earnings Call Transcript - Insider Monkey
JPMorgan cuts CVRx stock rating, slashes price target to $7 By Investing.com - Investing.com India
CVRx (CVRX) Sees Downgrade and Price Target Reduction from JP Mo - GuruFocus
CVRx (CVRX) Reports Q1 Loss, Tops Revenue Estimates - MSN
CVRx Earnings Call: Growth Amidst Challenges - TipRanks
CVRx (CVRX) Shares Fall Following Q1 Sales Miss and Downgrade - GuruFocus
CVRx price target lowered to $12 from $20 at Piper Sandler - TipRanks
JPMorgan cuts CVRx stock rating, slashes price target to $7 - Investing.com
CVRx stock downgraded at J.P. Morgan on Q1 miss (CVRX:NASDAQ) - Seeking Alpha
Demystifying CVRx: Insights From 4 Analyst Reviews - Benzinga
CVRx (CVRX) Target Price Lowered by Piper Sandler | CVRX Stock N - GuruFocus
Analysts Offer Insights on Healthcare Companies: VYNE Therapeutics (VYNE) and CVRx (CVRX) - The Globe and Mail
Investors Appear Satisfied With CVRx, Inc.'s (NASDAQ:CVRX) Prospects As Shares Rocket 25% - simplywall.st
This National Vision Holdings Analyst Turns Bullish; Here Are Top 3 Upgrades For Friday - Benzinga
This International Paper Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday - Benzinga
JPMorgan Downgrades CVRx to Underweight From Neutral, Adjusts Price Target to $7 From $15 - marketscreener.com
Dave To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga
CVRx Q1 2025 revenue increases 15% to USD 12.3 million - Medical Buyer
CVRx: Q1 Earnings Snapshot - San Francisco Chronicle
CVRx downgraded to Underweight from Neutral at JPMorgan - TipRanks
CVRx Q1 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: CVRx Q1 2025 shows improved EPS, stock dips - Investing.com Nigeria
CVRx Inc (CVRX) Q1 2025 Earnings Call Highlights: Revenue Growth Amid Sales Force Realignment ... By GuruFocus - Investing.com Canada
Cvrx Inc Azioni (CVRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.56%
1.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):